Document is current
Any future updates will be listed below
-
Authors
Zhang, Yancong http://orcid.org/0000-0002-2768-2975
Bhosle, Amrisha
Bae, Sena
McIver, Lauren J.
Pishchany, Gleb
Accorsi, Emma K. http://orcid.org/0000-0002-7443-7921
Thompson, Kelsey N. http://orcid.org/0000-0002-9437-9722
Arze, Cesar http://orcid.org/0000-0002-3606-4183
Wang, Ya
Subramanian, Ayshwarya http://orcid.org/0000-0002-4134-7612
Kearney, Sean M.
Pawluk, April
Plichta, Damian R. http://orcid.org/0000-0002-6555-2557
Rahnavard, Ali http://orcid.org/0000-0002-9710-0248
Shafquat, Afrah
Xavier, Ramnik J.
Vlamakis, Hera http://orcid.org/0000-0003-1086-9191
Garrett, Wendy S. http://orcid.org/0000-0002-5092-0150
Krueger, Andy
Huttenhower, Curtis http://orcid.org/0000-0002-1110-0096
Franzosa, Eric A. http://orcid.org/0000-0002-8798-7068
- License Information
-
More Information
Article History
Received: 16 October 2020
Accepted: 15 March 2022
First Online: 25 May 2022
Competing interests
: C.H. is on the scientific advisory board of Seres Therapeutics and Empress Therapeutics. W.S.G. is on the scientific advisory board of Freya Biosciences, Senda Biosciences, Artizan Biosciences and Tenza. The laboratory of W.S.G. receives funding from Merck. R.J.X. is a member of the scientific advisory board of Nestle and Senda Biosciences. A.K. presents employment by Takeda that may gain or lose financially through this publication.
